CD40 is a 45-kDa glycoprotein member ofthe tumor necrosis factor receptor (TNFR) family expressed on B cells, thymic epithelial cells, dendritic cells, and some carcinoma cells. The unique capacity of CD40 to trigger immunoglobulin isotype switching is dependent on the activation of protein-tyrosine kinases, yet CD40 possesses no kinase domain and no known consensus sequences for binding to protein-tyrosine kinases. Recently, an intracellular protein (CD40bp/LAP-1/CRAF-1) which belongs to the family of TNFR-associated proteins was reported to associate with CD40. We describe a 23-kDa cell surface protein (p23) which is specifically associated with CD40 on B cells and on urinary bladder transitional carcinoma cells. Protein microsequencing revealed that p23 shows no homology to any known protein. A rabbit antibody raised against a peptide derived from p23 recognized a 23-kDa protein in CD40 immunoprecipitates. In contrast to CD40bp/LAP-1/CRAF-1, p23 was not associated with TNFR p80 (CD120b). These findings suggest that p23 is a novel member of the CD40 receptor complex.
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Interaction of the B-cell surface antigen CD40 with its ligand (CD40L) expressed on activated T cells plays a critical role in T-B cell collaboration, particularly in immunoglobulin isotype switching, in the induction of expression of B7 costimulatory molecules, in B-cell survival and in the formation of germinalcenter B cells (1) (2) (3) . This is evidenced by the observations that mice with a disrupted CD40 gene fail to undergo isotype switching and to develop germinal centers in response to T-cell-dependent antigens (4, 5) and that B cells from CD40-null mice fail to elicit an allogeneic response (G. Hollander, E. Castigli, and R.S.G., unpublished work).
The unique capacity of CD40 to trigger immunoglobulin class switching in B cells suggests that CD40 ligation activates a unique signaling pathway(s). Our studies and those of others indicate that CD40 ligation activates protein-tyrosine kinases (PTKs), including Lyn and Syk and results in tyrosine phosphorylation of multiple substrates, including phosphatidylinositol 3-kinase, phospholipase C-,y2, and a 28-kDa phosphoprotein (6, 7) . More importantly, PTK inhibitors and crosslinking of CD45 to CD40 inhibit CD40-mediated isotype switching (8, 9) . However, CD40 has no kinase domain and no known consensus sequence for binding to PTK, suggesting that CD40 uses associated molecules for transducing intracellular signals.
Recently, a member of the tumor necrosis factor receptor (TNFR)-associated factor (TRAF) family of proteins was found to bind to the cytoplasmic region of CD40 and to play a role in CD40-mediated induction of CD23 expression (10) (11) (12) . We have identified and biochemically characterized a 23-kDa cell surface protein (p23) associated with human CD40. p23 was not associated with CD95 (Fas) or with TNFR p80 (CD120b), suggesting that it could be important in CD40-specific signaling.
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MATERIALS AND METHODS Cells. The human B-cell lines Raji, BJAB, and Ramos and the human bladder carcinoma cell line T24 were obtained from American Type Culture Collection. The human B-cell line Jijoye which expresses TNFR p80 (CD120b) was a kind gift from G. Mosialos and E. Kieff (Harvard Medical School). Human tonsil B cells were purified as described (13) .
Monoclonal Antibodies (mAbs) and Reagents. Mouse antihuman CD40 mAb 626.1 (IgGl) was a gift from S. M. Fu (University of Virginia, Richmond). Murine anti-major histocompatibility complex (MHC) class I mAb W6/32 (IgGl), and anti-HLA-DR mAb L243 (IgG2a) were obtained through American Type Culture Collection. Anti-MHC class II mAb 3B12 (IgGl) has been described (14) . Anti-human Fas mAb ZB-4 (IgGl) was obtained from Kamiya Biomedical (Thousand Oaks, CA). Rat anti-human TNFR p80 mAb was purchased from Genzyme. Anti-CD81 mAb 5A6 (IgGl) was kindly provided by S. Levy (Stanford University). Tunicamycin was obtained from Boehringer Mannheim. Phosphatidylinositol-specific phospholipase C (PI-PLC) was purchased from Calbiochem. Anti-p23 peptide polyclonal antibody was raised in rabbits against a 17-aa peptide derived from p23 and conjugated to keyhole limpet hemocyanin (KLH) and was absorbed with KLH as described (15) .
Surface lodination and Immunoprecipitation. Surface iodination and immunoprecipitation were carried out with Bolton-Hunter reagent (16 lized in a 9 M urea/2% (vol/vol) Nonidet P-40/5% (vol/vol) 2-mercaptoethanol and focused for 16 hr at 800 V in tube gels consisting of 9 (Fig. 1) . The association of p23 with CD40 was specific, since p23 was not detected in anti-HLA-DR immunoprecipitates (mAb L243) (Fig. 1, lane 3 (Fig. 1) . The association of p23 with CD40 was not restricted to B-lineage cells, since p23 was also detected in CD40 immunoprecipitates from the transitional bladder carcinoma cell line T24 (21) (Fig. 1) . Densitometric scanning of the intensity of the p23 and CD40 bands revealed a consistently higher ratio of intensity of p23 to CD40 bands in BJAB and T24 cell lines than in Raji and tonsil B cells. This suggests that the strength of the p23-CD40 association and/or the fraction of CD40 molecules associated with p23 varies in different cell lines. The migration of p23 in SDS/polyacrylamide gels was similar in reducing and nonreducing conditions (data not shown), indicating that p23 does not exist in a disulfide-linked complex. Jijoye B-cell line (Fig. 2B ) even after prolonged exposure of the autoradiographs (up to 10 days).
One potential candidate for p23 is the 22-to 24-kDa tetraspan molecule TAPA-1 (CD81), a cell surface protein associated with MHC class II molecules and with CD19 on B cells (19, 20) . However, p23 and TAPA-1 migrated differently in SDS/polyacrylamide gels (Fig. 3A) . More Fig. 4A. indicating that p23 is a cellular protein and not a serum protein that adsorbed to CD40. Incubation with tunicamycin at 10 Jg/ml for 1 hr prior to and throughout the 35S-labeling period did not result in a detectable shift in the migration of p23, suggesting that p23 may not be N-glycosylated. In contrast, as previously described (1), the migration of CD40 was shifted from 45 kDa to 39 kDa in tunicamycin-treated cells. Treatment of Raji cells with PI-PLC 0.25 unit/ml for 90 min prior to 125I-labeling did not alter the intensity of the p23 band detected in CD40 immunoprecipitates, suggesting that p23 is not a glycosylphosphatidylinositol-linked protein. PI-PLC treatment strongly reduced the density of the glycosylphosphatidylinositol-linked surface protein CD14 on monocytes (data not shown).
In an attempt to determine whether p23 consisted of more than one protein, we performed two-dimensional electrophoresis on CD40 immunoprecipitates from BJAB cells. The p23 from 1251-surface-labeled cells was detected as two closely located spots with pl values of 5.3 and 5.4 (Fig. SA) . Western blotting revealed that both spots reacted with antibody raised against the 17-aa peptide derived from p23 (data not shown). p23 intrinsically labeled with 35S was detected as a broad spot with a pl range of 5.3-5.4 (Fig. SB) . These data are compatible with the existence of a single 23-kDa protein with minor posttranslational modification.
We sequenced three internal tryptic peptides derived from p23 that were 7, 9, and 17 aa long. No significant matches were found with proteins in the National Biomedical Research Foundation data bank (as of March 1995). Rabbit polyclonal antibody against the 17-aa peptide detected a 23-kDa protein in Western blots of CD40 immunoprecipitates but not of MHC class II or MHC class I immunoprecipitates of BJAB cells (Fig.  6) . Western blot analysis of lysates from the Jurkat T-cell line and the myelomonocytic cell lines U-937 and THP-1 revealed the presence of p23 in all these lines (data not shown). This observation suggests that p23 can be expressed independently of CD40.
DISCUSSION
In this paper we report the association of a 23-kDa cell surface protein, p23, with CD40. p23 was found associated with CD40 in all B-cell lines examined, which included the Raji, BJAB (Fig. 1) , Jijoye (Fig. 2) , and Ramos cell lines and Epstein-Barr virus-transformed normal B cells (data not shown). p23 was also associated with CD40 in the single epithelial cell line examined.
The association of p23 with CD40 in B cells was specific and was not a peculiarity of transformed cell lines, since it was detected on normal tonsil B cells (Fig. 1) . The association of p23 and CD40 appears to be relatively weak, since it was disrupted by the strong detergent Nonidet P-40. p23 is likely to be a cell surface protein, since it was readily labeled by cell surface iodination, and is likely to be a transmembrane protein, since it was resistant to PI-PLC (Fig. 4B) . p23 was judged to be a cellular protein because it was labeled in cells incubated with 35S-labeled amino acids. It did not appear to be N-glycosylated, since its mobility did not change following treatment with tunicamycin (Fig. 4A) .
Several lines of evidence indicate that p23 is a novel protein. Although its apparent molecular weight is close to that of TAPA-1, p23 is clearly distinct from TAPA-1 because it migrated slightly slower than TAPA-1 and more importantly, it did not react in Western blots with anti-TAPA-1 mAb (Fig.  3) . The results of two-dimensional gel electrophoresis were compatible with p23 consisting of a single species with minor posttranslational modification (Fig. 5) , although we cannot completely rule out the presence of two protein species. The strongest evidence for p23 being a novel protein was provided by the unique amino acid sequences obtained for all three tryptic internal peptides derived from p23. Furthermore, a nonprecipitating rabbit antibody raised against one of these peptides recognized in Western blots a single 23-kDa protein in CD40 immunoprecipitates but not in MHC class I or MHC class II immunoprecipitates (Fig. 6 ). Taken together, these results strongly suggest that p23 is neither an already identified protein nor a breakdown product of CD40.
The mode of association of p23 with CD40 and the role of p23 in CD40 signaling remain to be determined. Preliminary experiments using chimeric molecules consisting of the extracellular domain of CD8 and of the transmembrane and intracellular domains of CD40 transfected into BJAB cells indicate that p23 associates with the extracellular domain of CD40 and is important for CD40-mediated cell aggregation. This suggests that p23 plays a role in CD40 signaling. Interestingly, Faris et al. (7) reported, and we have confirmed, that CD40 ligation on B cells leads to the transient tyrosine phosphorylation of an 28-kDa protein which could represent a phosphorylated form of p23. Generation of an immunoprecipitating antibody to p23 is required to address this question.
Recently, a 63-kDa intracellular protein (CD40bp/LAP-1/ CRAF-1) belonging to the TRAF family has been found to associate with the cytoplasmic domain of CD40 (10) (11) (12) . Like p23, this protein can be expressed independently of CD40 (11, 12) . In one report CD40bp/LAP-1/CRAF-1 was found to associate with TNFR p80 and the lymphotoxin ,3 receptor (1 1), raising the possibility that other components of the CD40 complex may be required for CD40-specific functions such as isotype switching. p23 was not found to associate with TNFR p8O or with Fas, another member of the TNFR family (Fig. 2) . The exact role of p23 in CD40 signaling and function will require the cloning of this molecule.
